Home / PPBT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPBT make money? Does PPBT have pricing power? What's the Earnings Whisper? Will PPBT profit more as the business scales? What is PPBT's management track record? Is PPBT's current price justified?

Purple Biotech Ltd.

$1.72 -$4.88 (-73.94%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$1.74

Day Range

$1.62$1.79

Year Range

$1.16$14.1

Market Cap

237.5K

AVG Volume

1.11M

Trailing/Forward PE

-0.01/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD) · TTM

PPBT Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD) · TTM

PPBT Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-24.49M
26 Q1	-26.02M
25 Q4	-26.39M
25 Q3	-3.25M
25 Q2	-2.61M
25 Q1	-3.93M
24 Q4	-7.24M
24 Q3	-11.66M
24 Q2	-16.03M
24 Q1	-18.76M

Operating Income (USD) · TTM

PPBT Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-28.36M
26 Q1	-28.3M
25 Q4	-27.45M
25 Q3	-5.03M
25 Q2	-5.79M
25 Q1	-8.01M
24 Q4	-11.07M
24 Q3	-16.32M
24 Q2	-19.94M
24 Q1	-21.61M

EBITDA (USD) · TTM

PPBT EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-24.28M
26 Q1	-25.84M
25 Q4	-26.23M
25 Q3	-3.55M
25 Q2	-2.41M
25 Q1	-3.71M
24 Q4	-7.05M
24 Q3	-11.14M
24 Q2	-16.02M
24 Q1	-18.64M

Cash Flows (USD) · TTM

PPBT Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-7.76M
26 Q1	-6.8M
25 Q4	-5.66M
25 Q3	-6.6M
25 Q2	-8.83M
25 Q1	-11.26M
24 Q4	-14.37M
24 Q3	-17.34M
24 Q2	-17.7M
24 Q1	-18.94M

EPS (USD) · TTM

PPBT EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-2.22
26 Q1	-2.66
25 Q4	-2.84
25 Q3	-2.86
25 Q2	-6.38
25 Q1	-23.38
24 Q4	-51
24 Q3	-86.8
24 Q2	-129.2
24 Q1	-160.8

Expenses (USD) · TTM

PPBT Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	7.62M
26 Q1	7.56M
25 Q4	6.71M
25 Q3	4.78M
25 Q2	5.55M
25 Q1	7.56M
24 Q4	10.62M
24 Q3	15.93M
24 Q2	19.54M
24 Q1	21.42M

Shares Outstanding · TTM

PPBT Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	-317K
26 Q1	-309K
25 Q4	-309K
25 Q3	-318K
25 Q2	-250K
25 Q1	-409K
24 Q4	-582K
24 Q3	-797K
24 Q2	-1.11M
24 Q1	-1.39M

Employee Count

PPBT Employee Count by quarter
Period	Employee Count
2025	10
2024	9
2023	20
2022	20
2021	19
2020	13
2019	9
2018	10
2017	9
2016	7

Free Cash Flow Yield

PPBT Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-41.55%
Sep 26	-40.83%
Aug 26	-42.54%
Aug 26	-45.52%
Aug 26	-47.64%
Aug 26	-49.97%
Jul 26	-51.98%
Jul 26	-50.89%
Jul 26	-49.5%
Jul 26	-46.64%
Jul 26	-42.8%
Jun 26	-43.31%
Jun 26	-42.8%
Jun 26	-46.05%
Jun 26	-24.5%
May 26	-24.34%
May 26	-25.27%
May 26	-18.47%
May 26	-11.51%
May 26	-11.31%
Apr 26	-10.47%
Apr 26	-9.76%
Apr 26	-11.51%
Apr 26	-11.56%
Mar 26	-11.85%
Mar 26	-11.94%
Mar 26	-11.59%
Mar 26	-30.32%
Feb 26	-32.79%
Feb 26	-29.28%
Feb 26	-25.03%
Feb 26	-24.08%
Jan 26	-24%
Jan 26	-21.83%
Jan 26	-22.9%
Jan 26	-20.97%
Jan 26	-21.96%
Dec 25	-20.53%
Dec 25	-20.5%
Dec 25	-19.27%
Dec 25	-17.44%
Nov 25	-39.07%
Nov 25	-42.13%
Nov 25	-44.95%
Nov 25	-39.45%
Oct 25	-41.11%
Oct 25	-54.7%
Oct 25	-53.08%
Oct 25	-54.7%
Oct 25	-54.33%
Sep 25	-53.87%
Sep 25	-55.35%
Sep 25	-56.62%
Sep 25	-48.9%
Aug 25	-16.22%
Aug 25	-14.06%
Aug 25	-13.97%
Aug 25	-15.15%
Aug 25	-19.71%
Jul 25	-18.35%
Jul 25	-16.45%
Jul 25	-17.82%
Jul 25	-17.24%
Jun 25	-18.28%
Jun 25	-18.59%
Jun 25	-17.45%
Jun 25	-16.35%
May 25	-16.45%
May 25	-291.96%
May 25	-308.43%
May 25	-317.52%
May 25	-301.78%
Apr 25	-259.31%
Apr 25	-246.52%
Apr 25	-280.05%
Apr 25	-271.89%
Mar 25	-252.3%
Mar 25	-255.99%
Mar 25	-256.93%
Mar 25	-356%
Feb 25	-335.69%
Feb 25	-315.57%
Feb 25	-322.7%
Feb 25	-333.45%
Jan 25	-307.8%
Jan 25	-273.32%
Jan 25	-282.59%
Jan 25	-257.16%
Jan 25	-221.81%
Dec 24	-229.44%
Dec 24	-292.5%
Dec 24	-261.19%
Dec 24	-213.3%
Nov 24	-298.17%
Nov 24	-586.93%
Nov 24	-513.12%
Nov 24	-457.43%
Nov 24	-413.3%
Oct 24	-313.51%
Oct 24	-294.14%

Price to Sales

PPBT Price to Sales by quarter
Period	Price to Sales
Aug 21	164.04
Aug 21	160.22
Aug 21	164.04
Aug 21	175.51
Jul 21	191.85
Jul 21	172.04
Jul 21	173.77
Jul 21	163.35
Jul 21	165.43
Jun 21	172.04
Jun 21	177.25
Jun 21	174.82
Jun 21	206.1
May 21	48.52
May 21	42.12
May 21	35.72
May 21	35.28
Apr 21	37.5
Apr 21	40.43
Apr 21	34.3
Apr 21	38.66
Apr 21	37.59
Mar 21	37.41
Mar 21	41.32
Mar 21	43.1
Mar 21	36.79
Feb 21	42.21
Feb 21	52.7
Feb 21	52.79
Feb 21	42.3
Jan 21	35.28
Jan 21	40.97
Jan 21	38.75
Jan 21	35.55
Dec 20	33.86
Dec 20	36.7
Dec 20	36.26
Dec 20	37.06
Dec 20	37.24
Nov 20	25.36
Nov 20	24.4
Nov 20	24.94
Nov 20	24.58
Oct 20	24.88
Oct 20	28.42
Oct 20	26.02
Oct 20	26.8
Oct 20	26.02
Sep 20	24.4
Sep 20	25.78
Sep 20	25.24
Sep 20	24.64
Aug 20	26.86
Aug 20	28.66
Aug 20	31.69
Aug 20	52.28
Jul 20	48.23
Jul 20	45.07
Jul 20	46.21
Jul 20	49.32
Jul 20	55.88
Jun 20	69.7
Jun 20	34.19
Jun 20	26.97
Jun 20	29.92
May 20	13.11
May 20	15.15
May 20	13.67
May 20	12.64
May 20	9.74
Apr 20	8.77
Apr 20	10.72
Apr 20	10.02
Apr 20	8.14
Mar 20	9.55
Mar 20	6.96
Mar 20	6.43
Mar 20	16
Feb 20	11.73
Feb 20	12.51
Feb 20	14.66
Feb 20	13.88
Jan 20	14.27
Jan 20	16.23
Jan 20	16.42
Jan 20	16.35
Jan 20	15.34
Dec 19	14.86
Dec 19	14.47
Dec 19	13.65
Dec 19	14.1
Nov 19	14.47
Nov 19	13.81
Nov 19	13.62
Nov 19	13.58
Nov 19	14.62
Oct 19	14.04
Oct 19	14.36
Oct 19	13.81
Oct 19	14.25

Price to Book

PPBT Price to Book by quarter
Period	Price to Book
Sep 26	1.53
Sep 26	1.56
Aug 26	1.49
Aug 26	1.4
Aug 26	1.33
Aug 26	1.27
Jul 26	1.35
Jul 26	1.38
Jul 26	1.42
Jul 26	1.51
Jul 26	1.64
Jun 26	1.63
Jun 26	1.64
Jun 26	1.53
Jun 26	2.87
May 26	2.89
May 26	2.79
May 26	3.81
May 26	5.09
May 26	5.18
Apr 26	5.6
Apr 26	6
Apr 26	5.09
Apr 26	5.07
Mar 26	4.94
Mar 26	4.91
Mar 26	5.06
Mar 26	0.66
Feb 26	0.61
Feb 26	0.69
Feb 26	0.8
Feb 26	0.84
Jan 26	0.84
Jan 26	0.92
Jan 26	0.88
Jan 26	0.96
Jan 26	0.92
Dec 25	0.98
Dec 25	0.98
Dec 25	1.04
Dec 25	1.15
Nov 25	0.71
Nov 25	0.65
Nov 25	0.61
Nov 25	0.7
Oct 25	0.67
Oct 25	0.5
Oct 25	0.52
Oct 25	0.5
Oct 25	0.51
Sep 25	0.51
Sep 25	0.5
Sep 25	0.49
Sep 25	0.56
Aug 25	1.7
Aug 25	1.96
Aug 25	1.97
Aug 25	1.82
Aug 25	1.75
Jul 25	1.88
Jul 25	2.09
Jul 25	1.93
Jul 25	2
Jun 25	1.88
Jun 25	1.85
Jun 25	1.97
Jun 25	2.11
May 25	2.09
May 25	0.15
May 25	0.14
May 25	0.14
May 25	0.14
Apr 25	0.17
Apr 25	0.18
Apr 25	0.16
Apr 25	0.16
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Feb 25	0.18
Feb 25	0.19
Feb 25	0.18
Feb 25	0.18
Jan 25	0.19
Jan 25	0.22
Jan 25	0.21
Jan 25	0.23
Jan 25	0.27
Dec 24	0.26
Dec 24	0.2
Dec 24	0.23
Dec 24	0.28
Nov 24	0.2
Nov 24	0.1
Nov 24	0.12
Nov 24	0.13
Nov 24	0.15
Oct 24	0.19
Oct 24	0.2

No video analysis for this stock yet. Request one from our team.

News: PPBT

globenewswire.com · 2 Sep 2026

New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies

REHOVOT, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the “Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy platform designed to maximize anti-cancer activity while minimizing toxicity, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering tri-specific antibody constructs and methods of use. The patent allowance further expands the Company's intellectual property portfolio supporting its proprietary CAPTN-3 platform for conditionally activated multispecific antibodies.

defenseworld.net · 31 Aug 2026

Financial Review: Ionis Pharmaceuticals (NASDAQ:IONS) & Purple Biotech (NASDAQ:PPBT)

Ionis Pharmaceuticals (NASDAQ: IONS - Get Free Report) and Purple Biotech (NASDAQ: PPBT - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations. Earnings and Valuation This table compares Ionis Pharmaceuticals

defenseworld.net · 4 Aug 2026

Purple Biotech (PPBT) Expected to Announce Quarterly Earnings on Wednesday

Purple Biotech (NASDAQ: PPBT - Get Free Report) will likely be announcing its results before the market opens on Wednesday, August 5th. Analysts expect Purple Biotech to announce earnings of ($0.98) per share for the quarter. Purple Biotech (NASDAQ: PPBT - Get Free Report) last announced its quarterly earnings data on Saturday, May 16th. The company reported